Nonalcoholic fatty liver disease and metabolic syndrome in postmenopausal women

References

• Livingston EH, Zylke JW. Progress in obesity research. Reasons for optimism. JAMA 2012;308:1162–4
   PubMedGoogle Scholar
• Flegal KM, Carroll MD, Kit BK, Ogden BK. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA 2012;307:491–7
   PubMed Web of Science ®Google Scholar
• Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab 2004;89:2583–9
   PubMed Web of Science ®Google Scholar
• Kowdley KV, Caldwell S. Nonalcoholic steatohepatitis. A twenty-first century epidemic? J Clin Gastroenterol 2006;40:S2–4
   Web of Science ®Google Scholar
• Niederau C. NAFLD and NASH. In: Mauss S, Berg T, Rockstroh J, et al., eds. Hepatology. A clinical textbook. 2nd ed. Germany: Flying Publisher; 2012:427–36
   Google Scholar
• Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221–31
   PubMed Web of Science ®Google Scholar
• Polyzos SA, Kountouras J, Zavos C, Tsiaousi E. The role of adiponectin in the pathogenesis and treatment of nonalcoholic fatty liver disease. Diabetes Obes Metab 2010;12:365–83
   PubMed Web of Science ®Google Scholar
• Torres DM, Williams CD, Harrison SA. Features, diagnosis, and treatment of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2012;10:837–58
   PubMed Web of Science ®Google Scholar
• Caballería L, Auladell MA, Torán P, et al. Risk factors associated with non-alcoholic fatty liver disease in subjects from primary care units. A case-control study. BMC Gastroenterol 2008;8:44–50
   PubMed Web of Science ®Google Scholar
• Adams LA, Lymp JF, St Sauver J, et al. The Natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterol 2005;12:113–21
   Google Scholar
• McCullough AJ. Pathophysiology of nonalcoholic steatohepatitis. J Clin Gastroenterol 2006;40:S17–29
   PubMed Web of Science ®Google Scholar
• Stefan N, Kantartzis K, Haring HU. Causes and metabolic consequences of fatty liver. Endocr Rev 2008;29:939–60
   PubMed Web of Science ®Google Scholar
• Ratziu V, Bellentani S, Cortez-Pinto H, et al. A position statement on NAFLD/NASH based on the EASL 2009 Special Conference. J Hepatol 2010;53:372–84
   PubMed Web of Science ®Google Scholar
• Clark JM. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol 2006;40:S5–10
   PubMed Web of Science ®Google Scholar
• Paschos P, Paletas K. Nonalcoholic fatty liver disease and metabolic syndrome. Hippokratia 2009;13:9–19
   PubMed Web of Science ®Google Scholar
• Kojima S, Watanabe N, Numata M, et al. Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background. J Gastroenterol 2003;38:954–61
   PubMed Web of Science ®Google Scholar
• Bellentani S, Saccoccio G, Masutti F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 2000;132:112–17
   PubMed Web of Science ®Google Scholar
• Caballerıa L, Pera G, Rodriguez L, et al. Metabolic syndrome and nonalcoholic fatty liver disease in a Spanish population: influence of the diagnostic criteria used. Eur J Gastroenterol Hepatol 2012;24:1007–11
   PubMed Web of Science ®Google Scholar
• Day CP, James OF. Steatohepatitis: a tale of two ‘‘hits’’? Gastroenterol 1998;114:842–5
   PubMed Web of Science ®Google Scholar
• Hijona E, Hijona L, Arenas JI, Bujanda L. Inflammatory mediators of hepatic steatosis. Mediators Inflamm 2010;2010:837419
   PubMedGoogle Scholar
• Madan K, Bhardwaj P, Thareja S, et al. Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD). J Clin Gastroenterol 2006;40:930–5
   PubMed Web of Science ®Google Scholar
• Petta S, Muratore C, Craxì A. Non-alcoholic fatty liver disease pathogenesis: the present and the future. Dig Liver Dis 2009;41:615–25
   PubMedGoogle Scholar
• Dowman JK, Tomlinson JW, Newsome PN. Pathogenesis of non-alcoholic fatty liver disease. Q J Med 2010;103:71–83
   Google Scholar
• Trujillo ME, Scherer PE. Adipose tissue-derived factors: impact on health and disease. Endoc Rev 2006;27:762–78
   PubMed Web of Science ®Google Scholar
• Dandona P, Weinstock R, Thusu K, et al. Tumor necrosis factor-alpha in sera of obese patientes: fall with weight loss. J Clin Endocrinol Metab 1998;83:2907–10
   PubMed Web of Science ®Google Scholar
• Pittas AG, Joseph NA, Greenberg AS. Adipocytokines and insulin resistance. J Clin Endocrinol Metab 2004;89:447–52
   PubMed Web of Science ®Google Scholar
• Tarantino G, Conca P, Pasanisi F, et al. Could inflammatory markers help diagnose nonalcoholic steatohepatitis? Eur J Gastroenterol Hepatol 2009;21:504–11
   PubMed Web of Science ®Google Scholar
• Jarrar MH, Baranova A, Collantes R, et al. Adipokines and cytokines in non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2008;27:412–21
   PubMed Web of Science ®Google Scholar
• Ziemke F, Mantzoros CS. Adiponectin in insulin resistance: lessons from translational research. Am J Clin Nutr 2010;91:258S–61S
   PubMed Web of Science ®Google Scholar
• Turer AT, Scherer PE. Adiponectin: mechanistic insights and clinical implications. Diabetologia 2012;55:2319–26
   PubMed Web of Science ®Google Scholar
• Yamauchi T, Kamon J, Minokoshi Y, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nature Med 2002;8:1288–95
   PubMed Web of Science ®Google Scholar
• Pagano C, Soardo G, Esposito W, et al. Plasma adiponectin is decreased in nonalcoholic fatty liver disease. Eur J Endocrinol 2005;152:113–18
   PubMed Web of Science ®Google Scholar
• Milewicz A, Jedrzejuk D, Dunajska K, Lwow F. Waist circunference and serm adiponectin levels in obese and non-obese postmenopausal women. Maturitas 2010;65:272–5
   PubMed Web of Science ®Google Scholar
• Li S, Shin HJ, Ding EL, van Dam RM. Adiponectin levels and risk of type 2 diabetes. A sistematic review and meta-analysis. JAMA 2009;302:179–88
   PubMed Web of Science ®Google Scholar
• Dowman JK, Tomlinson JW, Newsome PN. Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Aliment Pharmacol Ther 2011;33:525–40
   PubMed Web of Science ®Google Scholar
• Francque S, De Maeght S, Adler M, et al. High prevalence of advanced fibrosis in association with the metabolic syndrome in a Belgian prospective cohort of NAFLD patients with elevated ALT. Results of the Belgian NAFLD registry. Acta Gastroenterol Belg 2011;74:9–16
   PubMedGoogle Scholar
• Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterol 2002;123:745–50
   PubMed Web of Science ®Google Scholar
• Rector RS, Thyfault JP, Wei Y, Ibdah JA. Non-alcoholic fatty liver disease and the metabolic syndrome: an update. World J Gastroenterol 2008;14:185–92
   PubMed Web of Science ®Google Scholar
• Hernaez R, Lazo M, Bonekamp S, et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatol 2011;54:1082–90
   PubMed Web of Science ®Google Scholar
• Loria P, Adinolfi LE, Bellentani S, et al. Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. Dig Liver Dis 2010;42:272–82
   PubMedGoogle Scholar
• AGA (American Gastroenterological Association). American Gastroenterological Association Medical Position Statement: nonalcoholic fatty liver disease. Gastroenterol 2002;123:1702–4
   PubMedGoogle Scholar
• Ratziu V, Giral P, Charlotte F, et al. Liver fibrosis in overweight patients. Gastroenterol 2000;118:1117–23
   PubMed Web of Science ®Google Scholar
• Harrison SA, Oliver D, Arnold HL, et al. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut 2008;57:1441–7
   PubMed Web of Science ®Google Scholar
• Williamson RM, Price JF, Hayes PC, et al. Prevalence and markers of advanced liver disease in type 2 diabetes. Q J Med 2012;105:425–32
   Google Scholar
• Williams CD, Stengel J, Asike MI, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterol 2011;140:124–31
   PubMed Web of Science ®Google Scholar
• McPherson S, Stewart SF, Henderson E, et al. Simple non-invaisve fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. Gut 2010;59:1265–9
   PubMed Web of Science ®Google Scholar
• Lee CG, Carr MC, Murdoch SJ, et al. Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study. J Clin Endocrinol Metab 2009;94:1104–10
   PubMed Web of Science ®Google Scholar
• Suzuki A, Abdemalek F. Nonalcoholic fatty liver disease in women. Women’s Health 2009;5:1–13
   PubMedGoogle Scholar
• Hamaguchi M, Kojima T, Ohbora A, et al. Aging is a risk factor of non alcoholic fatty liver disease in pre-menopausal women. World J Gastroenterol 2012;18:237–43
   PubMed Web of Science ®Google Scholar
• Gutierrez-Grobe Y, Ponciano-Rodriguez G, Ramos MH, et al. Prevalence of nonalcoholic fatty liver disease in premenopausal, postmenopausal and polycystic ovary syndrome women. The role of estrogens. Ann Hepatol 2010;9:402–9
   PubMed Web of Science ®Google Scholar
• Nemoto Y, Toda K, Ono M, et al. Altered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice. J Clin Invest 2000;105:1819–25
   PubMed Web of Science ®Google Scholar
• Shimizu I, Ito S. Protection of estrogens against the progression of chronic liver disease. Hepatol Res 2007;37:239–47
   PubMed Web of Science ®Google Scholar
• Sowers MF, Zheng H, Tomey K, et al. Changes in body composition in women over six years at idlife: ovarian and chronological aging. J Clin Endocrinol Metab 2007;92:895–901
   PubMed Web of Science ®Google Scholar
• Mayes JS, Watson GH. Direct effects of sex steroid hormones on adipose tissues and obesity. Obes Rev 2004;5:197–216
   PubMedGoogle Scholar
• Toth MJ, Tchernof A, Sites CK, Poehlman ET. Effect of menopausal status on body composition and fat distribution. Int J Obes Relat Metab Disord 2000;24:226–31
   PubMed Web of Science ®Google Scholar
• Zhang C, Rexrode KM, van Dam RM, et al. Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality. Sixteen years of follow-up in US women. Circulation 2008;117:1658–67
   PubMed Web of Science ®Google Scholar
• Mosca L, Banka CL, Benjamin EJ, et al. Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women: 2007 update. Circulation 2007;115:1481–501
   PubMed Web of Science ®Google Scholar
• Schneider JG, Tompkins C, Blumenthal RS, Mora S. The metabolic syndrome in women. Cardiol Rev 2006;14:286–91
   PubMedGoogle Scholar
• Meigs JB. Epidemiology of the metabolic syndrome. Am J Manag Care 2002;8:283–92
   PubMed Web of Science ®Google Scholar
• Nahas EAP, Padoani NP, Nahas-Neto J, et al. Metabolic syndrome and its associated risk factors in Brazilian postmenopausal women. Climacteric 2009;12:431–8
   PubMed Web of Science ®Google Scholar
• NCEP. NCEP Expert Panel on the detection, evaluation, and treatment of high blood pressure in adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP). Adult Treatment Panel III (ATP III). JAMA 2001;285:2444–9
   Google Scholar
• Millen BE, Pencina MJ, Kimokoti RW, et al. Nutritional risk and the metabolic syndrome in women: opportunities for preventive intervention from the Framingham Nutrition Study. Am J Clin Nutr 2006;84:434–41
   PubMed Web of Science ®Google Scholar
• Olufadi R, Byrne CD. Clinical and laboratory diagnosis of the metabolic syndrome. J Clin Pathol 2008;61:697–706
   PubMed Web of Science ®Google Scholar
• Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1999;15:539–53
   Google Scholar
• International Diabetes Federation: The IDF consensus worldwide definition of metabolic syndrome, 2005. Available at: www.idf.org/webdata/docs/Mets-def-update2006.pdf
   Google Scholar
• Reaven GM. The metabolic syndrome: requiescat in pace. Clin Chem 2005;51:931–38
   PubMed Web of Science ®Google Scholar
• Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome. A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation. Circulation 2009;120:1640–5
   PubMed Web of Science ®Google Scholar
• Adams LA, Talwalkar JA. Diagnostic evaluation of nonalcoholic fatty liver disease. J Clin Gastroenterol 2006;40:S34–8
   Google Scholar
• Chen ZW, Chen LY, Dai HL, et al. Relationship between alanine aminotrasnferase levels and metabolic syndrome in nonalcoholic fatty liver disease. J Zhejiang Univ Sci B 2008;9:616–22
   PubMed Web of Science ®Google Scholar